Table 1 Patients and tumor characteristics at mCHT start.
Characteristics | āā„ā75Ā years (%) Nā=ā112 | ā<ā75Ā years (%) Nā=ā472 |
|---|---|---|
HR status (at primary diagnosis) | ||
Ā Ā Ā ER+ā/PgR+ā | 56 (50.0) | 318 (67.4) |
Ā Ā Ā ER+ā/PgRāāor Ā Ā Ā ERāā/PgR+ā | 22 (19.6) | 91 (19.3) |
Ā Ā Ā TNBC | 34 (30.4) | 63 (13.3) |
PS | ||
Ā Ā Ā 0 | 45 (40.2) | 300( 63.6) |
Ā Ā Ā 1 | 52 (46.4) | 138 (29.2) |
Ā Ā Ā 2 | 14 (12.5) | 28 (5.9) |
Ā Ā Ā 3 | 1 (ā) | 4 (ā) |
Ā Ā Ā Not available | 0 | 2 |
Metastatic sites | ||
Ā Ā Ā Bone | 63 (56.3) | 333 (70.6) |
Ā Ā Ā Lung | 25 (22.3) | 157 (33.3) |
Ā Ā Ā Liver | 30 (26.8) | 199 (42.2) |
Ā Ā Ā Soft tissue | 22 (19.6) | 88 (18.7) |
Ā Ā Ā Others | 35 (31.3) | 181 (38.3) |
Number of metastatic sites | ||
Ā Ā Ā 1 | 59 (52.7) | 147 (31.1) |
Ā Ā Ā 2 | 38 (33.9) | 200 (42.4) |
Ā Ā Ā āā„ā3 | 12 (10.7) | 118 (25.0) |
Ā Ā Ā NA | 3 (2.7) | 7 (1.4) |
Number of treatments before mCHT | ||
Ā Ā Ā 0 | 37 (33.0) | 74 (15.7) |
Ā Ā Ā 1 | 33 (29.5) | 84 (17.8) |
Ā Ā Ā 2 | 17 (15.2) | 106 (22.5) |
Ā Ā Ā āā„ā3 | 25 (22.3) | 208 (44.1) |
